Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05055323
Title A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Thomas Jefferson University
Indications

pancreatic ductal adenocarcinoma

Therapies

Pyrvinium

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.